How much does a box of Sonidegib cost?

The U.S. Food and Drug Administration(FDA) approved Sonidegib to treat some patients with basal cell carcinoma (BCC), the most common non-melanoma skin cancer. The approval is for patients with a rare type of basal cell carcinoma that has become locally advanced because it has come back after previous surgery or radiation therapy, or their cancer is not amenable to surgery or radiation therapy.

Local advanced basal cell carcinoma can only be detected after it has penetrated deep into the skin, and in some cases, surgery and radiation therapy are not options. The FDA’s approval of solidegib is based on the results of an ongoing multi-center clinical trial. Among 66 patients with locally advanced basal cell carcinoma who received low-dose treatment, 38 (58%) experienced tumor shrinkage, and 3 of them had complete responses. Nearly 50% of patients had responses that lasted at least 6 months. Response rates were similar in patients who received the higher dose, but those treated at that dose had more severe side effects. The FDA-approved dose is 200 mg.

Solidagen is a new type of drug for treating diseases. Although the original drug Solidagen has been launched in China, it has not yet entered the scope of medical insurance. Its price has not yet been determined, and domestic patients cannot yet purchase this drug. The price of Solidegib Original drug, European version specifications200mg*30 capsules per box listed overseas is around RMB 46,000 (the price may fluctuate due to the exchange rate), which is relatively expensive. The ingredients of the two drugs are basically the same. When purchasing this drug overseas, you need to choose through formal channels. Currently, there are no generic drugs of Solidagen produced and put on the market. For specific price and drug information, please consult Yaode Medical Consultant.